BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15916446)

  • 1. Short-course therapy for community-acquired pneumonia in paediatric patients.
    Qazi S
    Drugs; 2005; 65(9):1179-92. PubMed ID: 15916446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How long should we treat community-acquired pneumonia?
    Scalera NM; File TM
    Curr Opin Infect Dis; 2007 Apr; 20(2):177-81. PubMed ID: 17496577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course antimicrobial therapy for community-acquired pneumonia.
    Kolditz M; Halank M; Höffken G
    Treat Respir Med; 2005; 4(4):231-9. PubMed ID: 16086597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
    Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
    Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.
    Greenberg D; Givon-Lavi N; Sadaka Y; Ben-Shimol S; Bar-Ziv J; Dagan R
    Pediatr Infect Dis J; 2014 Feb; 33(2):136-42. PubMed ID: 23989106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.
    Paladino JA; Adelman MH; Schentag JJ; Iannini PB
    Pharmacoeconomics; 2007; 25(8):677-83. PubMed ID: 17640109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
    Lodha R; Randev S; Kabra SK
    Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortening antibiotic duration for community acquired pneumonia.
    Melo L; Oliveira S
    Eur J Intern Med; 2018 May; 51():e21-e22. PubMed ID: 29454484
    [No Abstract]   [Full Text] [Related]  

  • 11. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective treatment strategies for paediatric community-acquired pneumonia.
    Atkinson M; Yanney M; Stephenson T; Smyth A
    Expert Opin Pharmacother; 2007 Jun; 8(8):1091-101. PubMed ID: 17516873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
    Opmeer BC; El Moussaoui R; Bossuyt PM; Speelman P; Prins JM; de Borgie CA
    J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of pneumonia therapy and the role of biomarkers.
    Kaziani K; Sotiriou A; Dimopoulos G
    Curr Opin Infect Dis; 2017 Apr; 30(2):221-225. PubMed ID: 28079629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of recent studies of community-acquired pneumonia.
    Higgins K; Singer M; Valappil T; Nambiar S; Lin D; Cox E
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S150-6. PubMed ID: 18986282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology of community-acquired bronchitis and pneumonia in young children and the choice of antibacterial therapy].
    Samsygina GA; Okhlopkova KA; Suslova OV
    Antibiot Khimioter; 2000; 45(11):29-30. PubMed ID: 11210300
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
    Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
    Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.
    Epstein BJ; Gums JG
    Drugs; 2005; 65(14):1949-71. PubMed ID: 16162020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.